Abstract
Purpose
The purpose of the study was to establish the mechanism by which the estrogen concentration difference between the follicular fluid and the serum is maintained.
Methods
We used dialysis membrane with a pore size of <3 KD to characterize the estrogen-binding capacity of the follicular fluid. We performed PCR, western blot, and ELISA on luteinized granulosa cells to determine if sex hormone-binding globulin (SHBG) is produced by granulosa cells, and finally we used affinity columns and mass spectrometry to identify the estrogen-binding protein in the follicular fluid.
Results
We found that a significant estrogen concentration difference is maintained in a cell-free system and is lost with proteolysis of the follicular fluid proteins. Luteinized granulosa cells are likely not a source of SHBG, as we were not able to detect expression of SHBG in these cells. Perlecan was the most highly enriched follicular fluid protein in the affinity columns.
Conclusions
We were able to identify perlecan as the most likely candidate for the major estrogen-binding protein in the follicular fluid.
Similar content being viewed by others
References
Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010.
Clarke HG, Hope SA, Byers S, Rodgers RJ. Formation of ovarian follicular fluid may be due to the osmotic potential of large glycosaminoglycans and proteoglycans. Reproduction. 2006;132(1):119–31. doi:10.1530/rep.1.00960.
Ben-Rafael Z, Mastroianni Jr L, Meloni F, Lee MS, Flickinger GL. Total estradiol, free estradiol, sex hormone-binding globulin, and the fraction of estradiol bound to sex hormone-binding globulin in human follicular fluid. J Clin Endocrinol Metab. 1986;63(5):1106–11.
Younglai EV, Short RV. Pathways of steroid biosynthesis in the intact graafian collicle of mares in oestrus. J Endocrinol. 1970;47(3):321–31.
Agrawal R, Jacobs H, Payne N, Conway G. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril. 2002;78(6):1164–9.
Loukovaara M, Carson M, Palotie A, Adlercreutz H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids. 1995;60(9):656–61.
Arakawa S, Kuramitsu HK. Cloning and sequence analysis of a chymotrypsinlike protease from Treponema denticola. Infect Immun. 1994;62(8):3424–33.
Fahrer J, Kranaster R, Altmeyer M, Marx A, Bürkle A. Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain length. Nucleic Acids Res. 2007;35(21), e143. doi:10.1093/nar/gkm944.
Fields S, Ternyak K, Gao H, Ostraat R, Akerlund J, Hagman J. The ‘zinc knuckle’ motif of early B cell factor is required for transcriptional activation of B cell-specific genes. Mol Immunol. 2008;45(14):3786–96. doi:10.1016/j.molimm.2008.05.018.
Hallahan TW, Shapiro R, Vallee BL. Dual site model for the organogenic activity of angiogenin. Proc Natl Acad Sci U S A. 1991;88(6):2222–6.
He MM, Voss J, Hubbell WL, Kaback HR. Arginine 302 (helix IX) in the lactose permease of Escherichia coli is in close proximity to glutamate 269 (helix VIII) as well as glutamate 325. Biochemistry. 1997;36(44):13682–7. doi:10.1021/bi971531b.
Hoke DE, Egan S, Cullen PA, Adler B. LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect Immun. 2008;76(5):2063–9. doi:10.1128/iai.01643-07.
Jordan RA, Preissler MT, Banas JA, Gosselin EJ. Production of genetically engineered biotinylated interleukin-2 and its application in a rapid nonradioactive assay for T-cell activation. Clin Diagn Lab Immunol. 2003;10(3):339–44.
Kawasaki H, Suyama E, Iyo M, Taira K. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res. 2003;31(3):981–7.
Kernstock RM, Girotti AW. Lipid transfer protein binding of unmodified natural lipids as assessed by surface plasmon resonance methodology. Anal Biochem. 2007;365(1):111–21. doi:10.1016/j.ab.2007.02.018.
Kosovský J, Durmanová V, Kúdelová M, Rezuchová I, Tkáciková L, Rajcáni J. A simple procedure for expression and purification of selected non-structural (alpha and beta) herpes simplex virus 1 (HSV-1) proteins. J Virol Methods. 2001;92(2):121–9.
La Gruta NL, Liu H, Dilioglou S, Rhodes M, Wiest DL, Vignali DA. Architectural changes in the TCR:CD3 complex induced by MHC:peptide ligation. J Immunol. 2004;172(6):3662–9.
Lapik YR, Misra JM, Lau LF, Pestov DG. Restricting conformational flexibility of the switch II region creates a dominant-inhibitory phenotype in Obg GTPase Nog1. Mol Cell Biol. 2007;27(21):7735–44. doi:10.1128/mcb.01161-07.
Lovrich SD, La Fleur RL, Jobe DA, Johnson JC, Asp KE, Schell RF, et al. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease. Clin Vaccine Immunol. 2007;14(5):635–7. doi:10.1128/cvi.00431-06.
Müller BM, Kistner U, Kindler S, Chung WJ, Kuhlendahl S, Fenster SD, et al. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron. 1996;17(2):255–65.
Nossal NG, Makhov AM, Chastain PD, Jones CE, Griffith JD. Architecture of the bacteriophage T4 replication complex revealed with nanoscale biopointers. J Biol Chem. 2007;282(2):1098–108. doi:10.1074/jbc.M606772200.
Pichaud F, Roux S, Frendo JL, Delage-Mourroux R, Maclouf J, de Vernejoul MC, et al. 1,25-Dihydroxyvitamin D3 induces NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human neonatal monocytes. Blood. 1997;89(6):2105–12.
Richter S, Lamppa GK. A chloroplast processing enzyme functions as the general stromal processing peptidase. Proc Natl Acad Sci U S A. 1998;95(13):7463–8.
Thomas NS, Pizzey AR, Tiwari S, Williams CD, Yang J. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon. J Biol Chem. 1998;273(37):23659–67.
Velazquez A, Reyes A, Chargoy J, Rosado A. Amino acid and protein concentrations of human follicular fluid. Fertil Steril. 1977;28(1):96–100.
Forges T, Gerard A, Hess K, Monnier-Barbarino P, Gerard H. Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells. Mol Cell Endocrinol. 2004;219(1-2):61–8.
Yang CH, Almomen A, Wee YS, Jarboe EA, Peterson CM, Janat-Amsbury MM. An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations. Cancer Med. 2015;4(7):1039–50. doi:10.1002/cam4.445.
Hammond GL. Access of reproductive steroids to target tissues. Obstet Gynecol Clin N Am. 2002;29(3):411–23.
Munell F, Suarez-Quian CA, Selva DM, Tirado OM, Reventos J. Androgen-binding protein and reproduction: where do we stand? J Androl. 2002;23(5):598–609.
Berube D, Seralini GE, Gagne R, Hammond GL. Localization of the human sex hormone-binding globulin gene (SHBG) to the short arm of chromosome 17 (17p12–p13). Cytogenet Cell Genet. 1990;54(1-2):65–7.
Eriksson AL, Lorentzon M, Mellstrom D, Vandenput L, Swanson C, Andersson N, et al. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab. 2006;91(12):5029–37.
Fortunati N, Raineri M, Cignetti A, Hammond GL, Frairia R. Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells: effect of locally produced SHBG. Steroids. 1998;63(5-6):282–4.
Hammond GL, Langley MS. Identification and measurement of sex hormone binding globulin (SHBG) and corticosteroid binding globulin (CBG) in human saliva. Acta Endocrinol (Copenh). 1986;112(4):603–8.
Hammond GL, Langley MS, Robinson PA. A liquid-phase immunoradiometric assay (IRMA) for human sex hormone binding globulin (SHBG). J Steroid Biochem. 1985;23(4):451–60.
Lahteenmaki PL, Hammond GL, Luukkainen T. Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacities. Acta Endocrinol (Copenh). 1983;102(2):307–13.
Murayama Y, Hammond GL, Sugihara K. The SHBG gene and hormone dependence of breast cancer: a novel mechanism of hormone dependence of MCF-7 human breast cancer cells based upon SHBG. Breast Cancer (Tokyo, Japan). 1999;6(4):338–43.
Niemi S, Maentausta O, Bolton NJ, Hammond GL. Time-resolved immunofluorometric assay of human SHBG. Steroids. 1988;52(4):413–4.
Speroff L, Fritz M. The preantral follicle. In: Fritz MA, editor. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011. p. 204–5.
Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53(1):58–68.
Farach-Carson MC, Warren CR, Harrington DA, Carson DD. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol. 2013. doi:10.1016/j.matbio.2013.08.004.
Farach-Carson MC, Carson DD. Perlecan—a multifunctional extracellular proteoglycan scaffold. Glycobiology. 2007;17(9):897–905. doi:10.1093/glycob/cwm043.
Farach-Carson MC, Hecht JT, Carson DD. Heparan sulfate proteoglycans: key players in cartilage biology. Crit Rev Eukaryot Gene Expr. 2005;15(1):29–48.
Schofield KP, Gallagher JT, David G. Expression of proteoglycan core proteins in human bone marrow stroma. Biochem J. 1999;343(Pt 3):663–8.
French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, et al. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol. 1999;145(5):1103–15.
Eriksen GV, Carlstedt I, Morgelin M, Uldbjerg N, Malmstrom A. Isolation and characterization of proteoglycans from human follicular fluid. Biochem J. 1999;340(Pt 3):613–20.
Yanagishita M. Proteoglycans and hyaluronan in female reproductive organs. EXS. 1994;70:179–90.
Princivalle M, Hasan S, Hosseini G, de Agostini AI. Anticoagulant heparan sulfate proteoglycans expression in the rat ovary peaks in preovulatory granulosa cells. Glycobiology. 2001;11(3):183–94.
Rodgers RJ, Irving-Rodgers HF. Formation of the ovarian follicular antrum and follicular fluid. Biol Reprod. 2010;82(6):1021–9. doi:10.1095/biolreprod.109.082941.
Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999;237:97–132.
de Agostini A. An unexpected role for anticoagulant heparan sulfate proteoglycans in reproduction. Swiss Med Wkly. 2006;136(37-38):583–90.
Gonzalez EM, Reed CC, Bix G, Fu J, Zhang Y, Gopalakrishnan B, et al. BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem. 2005;280(8):7080–7. doi:10.1074/jbc.M409841200.
Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem. 2003;278(19):17491–9. doi:10.1074/jbc.M210529200.
Hosseini G, Liu J, de Agostini AI. Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells. J Biol Chem. 1996;271(36):22090–9.
McArthur ME, Irving-Rodgers HF, Byers S, Rodgers RJ. Identification and immunolocalization of decorin, versican, perlecan, nidogen, and chondroitin sulfate proteoglycans in bovine small-antral ovarian follicles. Biol Reprod. 2000;63(3):913–24.
Irving-Rodgers HF, Harland ML, Rodgers RJ. A novel basal lamina matrix of the stratified epithelium of the ovarian follicle. Matrix Biol. 2004;23(4):207–17. doi:10.1016/j.matbio.2004.05.008.
Britt KL, Drummond AE, Cox VA, Dyson M, Wreford NG, Jones ME, et al. An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology. 2000;141(7):2614–23. doi:10.1210/endo.141.7.7578.
Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A. 1993;90(23):11162–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The project was approved by the institutional Research Ethics Board of Mount Sinai Hospital in Toronto, and participants provided informed consent.
Additional information
Capsule We were able to identify perlecan as the most likely candidate for the major estrogen-binding protein in the follicular fluid.
Rights and permissions
About this article
Cite this article
Bentov, Y., Jurisicova, A., Kenigsberg, S. et al. What maintains the high intra-follicular estradiol concentration in pre-ovulatory follicles?. J Assist Reprod Genet 33, 85–94 (2016). https://doi.org/10.1007/s10815-015-0612-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-015-0612-1